基于衰老的头癌治疗方法的未来前景
Bruna Haddad Palomares1, Manoela Domingues Martins2,3, Marco Antonio Trevizani Martins2,3
1Oral Diagnosis Department, Piracicaba School of Dentistry, State University of Campinas, Piracicaba 13414-903, SP, Brazil.
Cancers
|June 26, 2025
概括
细胞衰老,一种永久性细胞循环停止的状态,可以抑制瘤,但也可以促进炎症. 了解衰老是开发新癌症疗法的关键,尤其是头癌 (HNC).
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 细胞衰老是一种稳定的细胞循环停止,由DNA损伤等压力因素引发.
- 衰老细胞分泌影响微环境的因素 (衰老相关的分泌表型,SASP).
- 衰老具有双重作用:抑制瘤和促进炎症/瘤发生.
研究的目的:
- 审查细胞衰老在癌症生物学中的作用.
- 讨论新兴的老化向治疗方法.
- 检查衰老在头癌 (HNC) 和诱导衰老治疗潜力的作用.
主要方法:
- 关于细胞衰老,SASP和癌症生物学的文献综述.
- 对衰老在瘤抑制和促进中的双重作用的分析.
- 专注于头部和部癌症以及潜在的治疗策略.
主要成果:
- 细胞衰老是一个复杂的过程,具有有益的 (瘤抑制) 和有害的 (炎症,瘤发生) 影响.
- 老化相关的分泌表型 (SASP) 显著影响瘤微环境.
- 诱导衰老疗法显示出减轻头癌进展的前景.
结论:
- 了解细胞衰老的双重性质对于开发有效的癌症治疗至关重要.
- 向衰老为头癌提供了创新的治疗策略.
- 需要进一步的研究来优化基于衰老的疗法并克服挑战.
更多相关视频
07:39SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
24.2K
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
3.1K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Microorganisms in Medicine and Therapeutics
375
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
375
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Replicative Cell Senescence
3.8K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.8K
